|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1242990444 |
| 003 |
OCoLC |
| 005 |
20231120010536.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
210323s2021 enk o 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCO
|d YDX
|d OCLCF
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCA
|
| 019 |
|
|
|a 1241071116
|
| 020 |
|
|
|a 0128232765
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128232767
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128225271
|
| 035 |
|
|
|a (OCoLC)1242990444
|z (OCoLC)1241071116
|
| 050 |
|
4 |
|a RC280.B7
|
| 082 |
0 |
4 |
|a 616.99481
|2 23
|
| 245 |
0 |
0 |
|a New targeting in the reversal of resistant glioblastomas /
|c edited by Ali Syed Arbab.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press is an imprint of Elsevier,
|c 2021.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer sensitizing agents for chemotherapy ;
|v volume 14
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Glioblastoma multiforme
|x Treatment.
|
| 650 |
|
0 |
|a Drug resistance in cancer cells.
|
| 650 |
|
2 |
|a Drug Resistance, Neoplasm
|0 (DNLM)D019008
|
| 650 |
|
6 |
|a Glioblastome
|0 (CaQQLa)201-0227421
|x Traitement.
|0 (CaQQLa)201-0377521
|
| 650 |
|
6 |
|a Cellules canc�ereuses
|x R�esistance aux m�edicaments.
|0 (CaQQLa)201-0217335
|
| 650 |
|
7 |
|a Drug resistance in cancer cells.
|2 fast
|0 (OCoLC)fst00898703
|
| 700 |
1 |
|
|a Arbab, Ali Syed,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t NEW TARGETING IN THE REVERSAL OF RESISTANT GLIOBLASTOMAS.
|d [Place of publication not identified] : ELSEVIER ACADEMIC PRESS, 2021
|z 0128225270
|w (OCoLC)1158478060
|
| 830 |
|
0 |
|a Cancer sensitizing agents for chemotherapy ;
|v v. 14.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128225271
|z Texto completo
|
